Drug Research

Johnson & Johnson will be paying $3.05 billion so as to acquire Halda Therapeutics, thereby getting a novel cell death platform while at the same time also strengthening its prostate cancer franchise that’s built on Erleada. At the mainstay of the...

Drug development is entering an era of radical transformation as pharmaceutical companies embrace virtual trials and in silico methodologies to reimagine the clinical research process. These digital-first strategies tap into computational models, artificial intelligence, and patient-specific simulations to address...

Innovations in Injectable and Parenteral Drug Delivery Systems The evolution of injectable drug delivery systems marks a transformative period in pharmaceutical therapeutics, where technological sophistication converges with patient-centered design to revolutionize how medications reach their targets. Global market valuations exceeding...

Exploring Novel Excipients for Next Generation Drug Formulation The landscape of pharmaceutical development finds itself at a critical juncture where the complexity of drug molecules increasingly outpaces the capabilities of traditional formulation approaches. Novel excipients drug formulation represents not merely...

Advances in Lipid-Based Drug Formulation for Solubility Enhancement The pharmaceutical industry faces a persistent challenge that threatens to derail promising drug candidates before they reach patients. Poor aqueous solubility afflicts over 70% of new molecular entities in development pipelines, creating...

Revolutionizing Oral Drug Delivery with Nanotechnology The pharmaceutical landscape stands at a transformative juncture where nanotechnology oral drug delivery systems are reshaping how medications reach their therapeutic targets. This convergence of nanoscience and pharmaceutical formulation addresses fundamental challenges that have...

Biopharmaceutical Formulation Challenges and Stability Solutions The biopharmaceutical revolution has fundamentally transformed therapeutic medicine, with protein-based therapeutics including monoclonal antibodies, fusion proteins, antibody-drug conjugates, and advanced biologic systems becoming cornerstones of treatment for cancer, autoimmune diseases, metabolic disorders, and numerous...